| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $346.8M | +1.2% |
| Cost of Revenue | $163.0M | -3.3% |
| R&D Expense | $32.6M | -5.5% |
| SG&A Expense | $80.7M | +4.8% |
| Operating Income | $20.8M | +214.0% |
| Pre-tax Income | $3.9M | +137.9% |
| Income Tax | -$485K | -104.7% |
| Net Income | $4.4M | +121.3% |
| EPS (Basic) | $0.29 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.9M | +101.6% |
| Accounts Receivable | $55.0M | +2.3% |
| Inventory | $623K | -18.8% |
| Current Assets | $104.6M | +15.9% |
| Total Assets | $402.5M | +2.1% |
| Current Liabilities | $58.0M | +9.4% |
| Long-term Debt | $164.6M | -4.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.0M | +15.0% |
| Capital Expenditures | $1.3M | -19.6% |
| Investing Cash Flow | -$14.7M | -457.3% |
| Financing Cash Flow | -$9.7M | +65.0% |
| Free Cash Flow | $35.6M | +16.9% |
| +121.0% |
| EPS (Diluted) | $0.29 | +121.0% |
| Total Liabilities |
| $224.6M |
| -0.5% |
| Stockholders' Equity | $178.0M | +5.5% |